This study is about using a special laser, called the super-pulsed carbon dioxide (CO₂) laser, to treat lumps or bumps on the eyelids. These lumps are called eyelid lesions. The laser treatment is being tested to see how well it works and how safe it is for different types of eyelid lesions. The study plans to include 2000 patients who have been diagnosed with eyelid lesions.

To join, patients must have eyelid lesions and no history of photosensitivity (sensitivity to light), bleeding problems, or blood clotting disorders. They should also be willing to attend follow-up appointments.

Some people cannot join the study. These include those with infections where the laser will be used, allergies to a pain reliever called lidocaine, those who easily develop keloids (thick scars), and pregnant or breastfeeding women. Also excluded are those with recent serious infections, active skin problems, major organ diseases, or a history of cancer or immune system issues.

• Participants will receive laser treatment for their eyelid lesions.
• Regular follow-up visits are required to monitor progress.
• The study aims to understand both the effectiveness and safety of the treatment.